참고문헌
- Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-36. https://doi.org/10.1056/NEJMra041536
- Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-66. https://doi.org/10.1056/NEJMoa063971
- Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008;14:367-78. https://doi.org/10.1093/humupd/dmn015
- Swain JE, Pool TB. ART failure: oocyte contributions to unsuccessful fertilization. Hum Reprod Update 2008;14:431-46. https://doi.org/10.1093/humupd/dmn025
- Kenigsberg S, Bentov Y, Chalifa-Caspi V, Potashnik G, Ofir R, Birk OS. Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol Hum Reprod 2009;15:89-103.
- Kang S, Tsai LT, Rosen ED. Nuclear mechanisms of insulin resistance. Trends Cell Biol 2016;26:341-51. https://doi.org/10.1016/j.tcb.2016.01.002
- Froment P, Gizard F, Defever D, Staels B, Dupont J, Monget P. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J Endocrinol 2006;189:199-209. https://doi.org/10.1677/joe.1.06667
- Huang Z, Zhou X, Nicholson AC, Gotto AM Jr, Hajjar DP, Han J. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor. Br J Pharmacol 2008;155:596-605.
- Komar CM. Peroxisome proliferator-activated receptors (PPARs) and ovarian function: implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod Biol Endocrinol 2005;3:41. https://doi.org/10.1186/1477-7827-3-41
- Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004;351:1106-18. https://doi.org/10.1056/NEJMra041001
- Qu F, Wang FF, Yin R, Ding GL, El-Prince M, Gao Q, et al. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med (Berl) 2012;90:911-23. https://doi.org/10.1007/s00109-012-0881-4
- Minge CE, Ryan NK, Van Der Hoek KH, Robker RL, Norman RJ. Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages. Biol Reprod 2006;74:153-60. https://doi.org/10.1095/biolreprod.105.043729
- Vural P, Degirmencioglu S, Saral NY, Akgul C. Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2010;150:61-5. https://doi.org/10.1016/j.ejogrb.2010.02.010
- Amalfi S, Velez LM, Heber MF, Vighi S, Ferreira SR, Orozco AV, et al. Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure. PLoS One 2012;7:e37658. https://doi.org/10.1371/journal.pone.0037658
- Subbaramaiah K, Lin DT, Hart JC, Dannenberg AJ. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2: evidence for involvement of activator protein-1 and CREB-binding protein/ p300. J Biol Chem 2001;276:12440-8. https://doi.org/10.1074/jbc.M007237200
- Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997;91:197-208. https://doi.org/10.1016/S0092-8674(00)80402-X
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
- Kim HJ, Kim CH, Lee SM, Choe SA, Lee JY, Jee BC, et al. Outcomes of preimplantation genetic diagnosis using either zona drilling with acidified Tyrode's solution or partial zona dissection. Clin Exp Reprod Med 2012;39:118-24. https://doi.org/10.5653/cerm.2012.39.3.118
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-8. https://doi.org/10.1006/meth.2001.1262
- Jansen E, Laven JS, Dommerholt HB, Polman J, van Rijt C, van den Hurk C, et al. Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol 2004;18:3050-63. https://doi.org/10.1210/me.2004-0074
- Haouzi D, Assou S, Monzo C, Vincens C, Dechaud H, Hamamah S. Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome. Hum Reprod 2012;27:3523-30. https://doi.org/10.1093/humrep/des325
-
Zaree M, Shahnazi V, Fayezi S, Darabi M, Mehrzad-Sadaghiani M, Darabi M, et al. Expression levels of
$PPAR{\gamma}$ and CYP-19 in polycystic ovarian syndrome primary granulosa cells: influence of${\omega}$ -3 fatty acid. Int J Fertil Steril 2015;9:197-204. -
Ramer R, Heinemann K, Merkord J, Rohde H, Salamon A, Linnebacher M, et al. COX-2 and
$PPAR-{\gamma}$ confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther 2013;12:69-82. - Sander VA, Hapon MB, Sicaro L, Lombardi EP, Jahn GA, Motta AB. Alterations of folliculogenesis in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 2011;124:58-64. https://doi.org/10.1016/j.jsbmb.2011.01.008
- Arif M, Thakur SC, Datta K. Disrupted hyaluronan binding protein 1 (HABP1) expression: one of the key mediator for ovarian dysfunction in polycystic ovary rat. Mol Cell Biochem 2015;398:233-44. https://doi.org/10.1007/s11010-014-2224-y
- Elkind-Hirsch KE. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome: impact on metabolic and reproductive abnormalities. Treat Endocrinol 2006;5:171-87. https://doi.org/10.2165/00024677-200605030-00005
-
Kim CH, Ahn JW, You RM, Kim SH, Chae HD, Kang BM. Pioglitazone treatment decreases follicular fluid levels of tumor necrosis factor-
${\alpha}$ and interleukin-6 in patients with polycystic ovary syndrome. Clin Exp Reprod Med 2011;38:98-102. https://doi.org/10.5653/cerm.2011.38.2.98 - Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 2003;101:1177-82.
- Samy N, Hashim M, Sayed M, Said M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers 2009;26:163-70. https://doi.org/10.1155/2009/465203
- Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000;49:497-505. https://doi.org/10.1007/s000110050622
- Chen Q, Sun X, Chen J, Cheng L, Wang J, Wang Y, et al. Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells. Reprod Biol Endocrinol 2009;7:147. https://doi.org/10.1186/1477-7827-7-147
피인용 문헌
- DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome vol.11, pp.None, 2017, https://doi.org/10.1186/s13148-019-0657-6
- Association of IL-17 and IL-23 follicular fluid concentrations and gene expression profile in cumulus cells from infertile women at risk for ovarian hyperstimulation syndrome vol.23, pp.4, 2020, https://doi.org/10.1080/14647273.2019.1566648